The investment would add capacity in research and development for manufacturing of active pharmaceutical ingredients (API), the main biologically active components of medicines, to supply its global clinical trials.
If you are not happy with the results below please do another search
50 search results for:
The company cited Gavi’s failure to procure the 350 million doses it had agreed to buy in May last year for the COVAX facility.
With a $1.36 billion buyout, Merck is bolstering its oncology program with the acquisition of Biotech Bay-based Imago Biosciences, a company focused on chronic bone marrow cancers.
The recreational use of nitrous oxide, also known as “laughing gas”, is on the rise in Europe among young people, producing worrying numbers of poisonings, the European Union drugs monitoring agency EMCDDA said in a study.
Topline data from Lysogene’s Phase II/III AAVance study showed its investigational gene therapy, LYS-SAF302, failed to meet its primary and key secondary efficacy endpoints in mucopolysaccharidosis type IIIA.
Capping a tumultuous year of legal battles, Teva Pharmaceuticals has found a new president and CEO. Effective Jan. 1, 2023, Richard Francis will take the company’s reins as Kåre Schultz retires.
Large pharmaceutical companies are making plans to comply with sustainability and carbon net zero targets. Hear from AstraZeneca and Merck KGaA’s MilliporeSigma about their strategies.
Former Theranos CEO Elizabeth Holmes will serve 11 years in prison on four counts of fraud, according to her sentencing by a federal judge in a California courtroom on Friday afternoon.
Philips, which has been struggling with a major recall of ventilators, on Monday flagged further problems with some machines it has previously replaced, according to an FDA statement.
With reproductive rights under attack and professional and personal challenges escalated as a result of the pandemic, women have been collectively called on to lead with not just authenticity, but also with compassion, kindness, and empathy. “In times of crisis, women take center stage. We are the peace makers, the solution seekers, the voice amplifiers,” said HBA interim CEO Wendy White at the 2022 HBA Annual Conference.